药物对比
Saxagliptin vs Tolbutamide
比较Saxagliptin（DPP-4抑制剂）与Tolbutamide（第一代磺脲类）治疗糖尿病。Saxagliptin低血糖较少；tolbutamide已过时且风险较高。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when considering a switch from an older sulfonylurea to a modern DPP-4 inhibitor in type 2 diabetes patients at hypoglycemia risk.
结论
Saxagliptin generally offers a better safety profile than tolbutamide, though neither is typically first-line therapy today.
全部药物对比